Physicians' Resource Center
Many of the members of our Medical Advisory Board work as clinicians for MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease patients in addition to their involvement in important research to further understanding of this relatively new disease which has an ever-changing landscape. Their work is often exploring a new frontier. We are pleased to provide a series of pages designed to highlight the important research publications and clinical trials by each center of MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease research. These publications are supplied with full permission from the experts onInflammation of the optic nerve that may be classified as unilateral (affecting one eye) or bilateral (affecting both eyes) that may result in vision changes, vision loss, and/or pain with eye movement. our Medical Advisory Board.
We also provide a page for where to find our latest grants, along with an order form for patient education materials.

The Neuroimmunology Laboratory
The Mayo Clinic
Dr. John Chen, Dr. Sean Pittock, and Dr. Eoin Flanagan support our mission by providing their latest research publications from The Mayo Clinic Neuroimmunology Laboratory, where remarkable work in research for of MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease has been performed. Their work in the area of MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease has made a huge impact in recent years. Our community is lucky to benefit from the resources presented by these experienced researchers and clinicians.

The MOG Initiative
The Neuroimmunology Clinic and Research Laboratory
Massachusetts General Hospital
Dr. Michael Levy is the head of The Neuroimmunology Clinic and Research Laboratory at Massachusetts General Hospital. His research in Neuromyelitis Optica (NMO) and Transverse Myelitis (TM)A disorder caused by inflammation of the spinal cord. It is characterized by symptoms and signs of neurologic dysfunction in motor and sensory tracts on both sides of the spinal cord. The involvement of motor and sensory control pathways frequently produce altered sensation, weakness and sometimes urinary or bowel dysfunction. In relation to MOGAD, the inflammation is caused by the MOG Antibody. is globally recognized. As he expands his research in the areas of rare neuroimmuneA term that refers to the components of the immune system that acts in and affects the central nervous system. disorders, MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease patients are now the recipient of his expertise as part of his MOGA type of protein involved in cell adhesion. Present throughout myelin sheaths. Initiative.
Grants for Research
Researchers: Explore MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease research funding opportunities.
Educational Materials Order Form
TMP will send healthcare professionals, public health professionals, community health workers, and researchers patient education materials. Complete this order form.
